NCT00905606View on ClinicalTrials.gov

Topiramate 25 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

June 30, 2001

Study Completion Date

June 30, 2001

Conditions
Healthy
Interventions
DRUG

Topiramate Tablets

DRUG

Topamax® Tablets

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00905606 - Topiramate 25 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter